Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.35 |
| ▸ | NR5A2 | O00482 | 5/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | NR5A1 | Q13285 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1010914 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL11181371 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL9122406 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL1012468 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL1011861 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL797511 | 0.98 | SCD (0.34) | SCDSPHK1NR5A2MEN1KMT2A | |
| SCHEMBL239983 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL21411456 | 0.82 | — | — | |
| SCHEMBL2961195 | 0.74 | SCD (0.45) | SCDNR5A2 | |
| SCHEMBL9340336 | 0.70 | SCD (0.50) | SCDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101044185-B | Photosensitive compositions based on polycyclic polymers | PROMERUS LLC | 2012-07-04 | — | — | CN | claimed |
| EP-1372844-B1 | HIGH ACTIVITY METAL CARBENE METATHESIS CATALYSTS GENERATED USING A THERMALLY ACTIVATED N-HETEROCYCLIC CARBENE PRECURSOR | CALIFORNIA INST OF TECHN (US) | 2011-01-05 | — | — | EP | claimed |
| EP-1771491-B1 | PHOTOSENSITIVE COMPOSITIONS BASED ON POLYCYCLIC POLYMERS | PROMERUS LLC (US) | 2009-11-18 | — | — | EP | claimed |
| EP-1981636-A1 | A MICROFLUIDIC METHOD AND STRUCTURE WITH AN ELASTOMERIC GAS-PERMEABLE GASKET | Elizarov, Arkadij (US) | 2008-10-22 | — | — | EP | claimed |
| US-20070200081-A1 | Microfluidic method and structure with an elastomeric gas-permeable gasket | SIEMENS MEDICAL SOLUTIONS USA, INC. | 2007-08-30 | — | — | US | claimed |
| WO-2007092472-A1 | A MICROFLUIDIC METHOD AND STRUCTURE WITH AN ELASTOMERIC GAS-PERMEABLE GASKET | ELIZAROV ARKADIJ (US) | 2007-08-16 | — | — | WO | claimed |
| US-6838489-B2 | High activity metal carbene metathesis catalysts generated using a thermally activated N-heterocyclic carbene precursor | CYMETECH, LLC (US) | 2005-01-04 | — | — | US | claimed |
| US-20030144437-A1 | High activity metal carbene metathesis catalysts generated using a thermally activated N-heterocyclic carbene precursor | STERLING JA, L.C. | 2003-07-31 | — | — | US | claimed |
| US-5468819-A | Process for making polymers containing a norbornene repeating unit by addition polymerization using an organo (nickel or palladium) complex | THE B.F. GOODRICH COMPANY (US) | 1995-11-21 | — | — | US | claimed |
| EP-0002277-B1 | RING-OPENED ALKYLNORBORNENE COPOLYMERS | The B.F. GOODRICH Company (US) | 1983-03-16 | — | — | EP | claimed |
| EP-0002277-A1 | Ring-opened alkylnorbornene copolymers | The B.F. GOODRICH Company (US) | 1979-06-13 | — | — | EP | claimed |
| US-4136248-A | POLYALKENAMERS, GLASS TRANSITION TEMPERATURE | THE B. F. GOODRICH COMPANY (US) | 1979-01-23 | — | — | US | claimed |
| WO-2025069809-A1 | RESIN COMPOSITION, RESIN MEMBRANE, FILM, FILM SET, OPTICAL WAVEGUIDE, PHOTOELECTRIC COMPOSITE SUBSTRATE, AND ELECTRONIC COMPONENT | 住友ベークライト株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20240279251-A1 | Monomer, Polymerizable Composition, and Polymers Derived Therefrom | 3M INNOVATIVE PROPERTIES COMPANY | 2024-08-22 | — | — | US | disclosed |
| WO-2024017654-A1 | COMPOSITE MATERIAL COMPRISING A ROMP-DERIVED POLYOLEFIN EMBEDDED IN A SILICONE MATRIX | VIPO FRANCE SAS (FR) | 2024-01-25 | — | — | WO | disclosed |
| US-20240002586-A1 | CURABLE COMPOSITIONS, COMPOSITE FOAM, METHOD OF MAKING THE SAME, AND ARTICLE INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2024-01-04 | — | — | US | disclosed |
| EP-0002277-A1 | Ring-opened alkylnorbornene copolymers | The B.F. GOODRICH Company (US) | 1979-06-13 | — | — | EP | disclosed |
| EP-0002278-A1 | Ring-opened dimethylnorbornene and isopropylnorbornene copolymers | The B.F. GOODRICH Company (US) | 1979-06-13 | — | — | EP | disclosed |
| US-4136247-A | POLYALKENAMERS, IMPACT STRENGTH, HEAT RESISTANCE | THE B. F. GOODRICH COMPANY (US) | 1979-01-23 | — | — | US | disclosed |
| US-4136248-A | POLYALKENAMERS, GLASS TRANSITION TEMPERATURE | THE B. F. GOODRICH COMPANY (US) | 1979-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279251-A1 | Monomer, Polymerizable Composition, and Polymers Derived Therefrom | PBRM1, CARM1, WASF2 | SCD 3034/4885SPHK1 2976/4885NR5A2 4027/4885 |
| US-20030144437-A1 | High activity metal carbene metathesis catalysts generated using a thermally activated N-heterocyclic carbene precursor | NQO1, NIT2, ALOX5 | SCD 210/4885SPHK1 3568/4885NR5A2 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.